Are There Predictive Factors for Autoimmune Reactions in Cancer Therapies?
Research is ongoing to identify predictive factors for autoimmune reactions in cancer therapies. Some studies suggest that patients with a history of autoimmune diseases may be at higher risk for developing autoimmune side effects from immunotherapies. Genetic factors, such as specific HLA types, and the presence of certain autoantibodies may also serve as potential predictive markers. However, more research is needed to validate these findings and apply them clinically.
